[--[65.84.65.76]--]
Indices, stocks & MCX commodities

Professional-Grade
Options Analytics

FII / DII flows

Market headlines

All stock news

Equity news

8
  • SAATVIKGL

    Saatvik green energy: plans to increase solar module production capacity from 4.8 gw to 8.8 gw by fy27, fueled by its 3.6 gw expansion in odisha.

  • COSMOFIRST

    Cosmo first: aims for full capacity use in films and chemicals, plans growth in specialty sales, and expanding consumer business in fy27.

  • HEXT

    Hexaware technologies: to purchase uk consulting firm through its uk subsidiary for up to gbp 11 million (~₹139.7 crore)

  • JKCEMENT

    Jk cement: gets approval letter for limestone mining lease in andhra pradesh covering 1,188 hectares.

  • TALBROAUTO

    Talbros automotive: secures new orders worth ₹800 crore, ₹100 crore from evs and ₹700 crore from exports for fy27 commercialization.

  • GPTINFRA

    Gpt infraprojects: company reveals highway improvement plan aiming to start work in fy27; plans to upgrade 25,000 km from 2-lane to 4-lane (₹10 lakh crore) and 16,000 km from 4-lane to 6-lane (₹6 lakh crore).

  • ARVSMART

    Arvind smartspaces: company forms investment platform with hdfc capital advisors for up to 1.25 billion rupees.

  • PACEDIGITK

    Pace digitek: company secures ₹264.65 crore deal from bsnl to design, build, and maintain bharatnet middle mile network in sikkim telecom circle.

Result news

8
  • POWERMECH

    Power mech project: q4 ebitda 2.27b rupees vs 2.2b (yoy) || q4 ebitda margin 10.75% vs 11.7% (yoy)

  • POWERMECH

    Power mech project: q4 cons net profit 1.53b rupees vs 1.2b (yoy) || q4 revenue 21.1b rupees vs 18.5b (yoy)

  • MEDPLUS

    Medplus health: q4 ebitda 1.69b rupees vs 1.4b (yoy) || q4 ebitda margin 9.07% vs 9.03% (yoy)

  • MEDPLUS

    Medplus health: q4 cons net profit 640m rupees vs 513m (yoy) || q4 revenue 18.6b rupees vs 15.1b (yoy)

  • WALCHANNAG

    Walchandnagar industries: q4 ebitda gain 42m rupees vs loss 471m (yoy)

  • WALCHANNAG

    Walchandnagar industries: q4 sl net profit 29m rupees vs loss 561m (yoy) || q4 revenue 930m rupees vs 531m (yoy)

  • PROTEAN

    Protean egov: q4 ebitda 378m rupees vs 179m (yoy) || q4 ebitda margin 12.31% vs 8.05% (yoy)

  • PROTEAN

    Protean egov: q4 cons net profit 304m rupees vs 204m (yoy) || q4 revenue 3.07b rupees vs 2.22b (yoy)

Built for traders

Real-time Data

Live market data with sub-second refresh rates for time-sensitive decisions

Institutional Flow

Track FII/DII activity across cash and derivatives segments

Deep Analytics

Strike-level OI, Greeks, IV analysis with multi-expiry comparison

Historical Data

Access years of historical OI, price, and volume data for backtesting

Custom Dashboards

Build personalized views with drag-and-drop widgets

Mobile Ready

Full-featured responsive design for trading on the go

Simple pricing

Monthly Perfect for getting started
399 /month
  • Ad-free experience
  • Multi-interval analysis
  • Auto data refresh
  • MyView dashboard
View plans
Yearly Best value for long-term traders
4199 /year
Save ₹1,596 (27% off)
  • All features in Quarterly
  • Best value plan
  • Priority support 24/7
  • Save more annually
View plans

Ready to trade smarter?

Join thousands of traders using NiftyInvest to make data-driven decisions. Start your free trial today.

50K+ Active Traders
1M+ Daily Data Points
99.9% Uptime